Shorla Pharma is an Irish specialty pharmaceutical company.
Shorla Pharma has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in October 2023.
Shorla Pharma's investors include Kurma Partners, Enterprise Ireland, Seroba Life Sciences.
Shorla Pharma is headquartered in Clonmel, Ireland.
Shorla Pharma is an Irish specialty pharmaceutical company.
Shorla Pharma is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shorla Pharma — Funding & Investors." VCBacked, October 4, 2023, https://www.vcbacked.co/company/shorla-pharma. Accessed October 28, 2026.
VCBacked. (2023). Shorla Pharma — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/shorla-pharma
{{cite web |title=Shorla Pharma — Funding & Investors |url=https://www.vcbacked.co/company/shorla-pharma |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated